Dicot Pharma AB (STO: DICOT)

Market Cap	411.79M
Revenue (ttm)	n/a
Net Income (ttm)	-52.66M
Shares Out	1.78B
EPS (ttm)	-0.06
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,278,653
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	0.096 - 0.576
Beta	1.39
Analysts	n/a
Price Target	n/a
Earnings Date	Feb 27, 2025

About Dicot Pharma AB

Dicot Pharma AB engages in the development of pharmaceutical products in Sweden. It is developing LIB-01 for the treatment of erectile dysfunction and premature ejaculation. The company was formerly known as Dicot AB (publ) and changed its name to Dicot Pharma AB in May 2024. Dicot Pharma AB was incorporated in 2015 and is based in Uppsala, Sweden.

• Industry: Pharmaceutical Preparations
• Founded: 2015
• Employees: 3
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: DICOT